Search Results - "KERR, Kathleen F"

Refine Results
  1. 1
  2. 2

    Zoom behavior during visual search modulates pupil diameter and reflects adaptive control states by Brunyé, Tad T, Drew, Trafton, Kerr, Kathleen F, Shucard, Hannah, Powell, Kate, Weaver, Donald L, Elmore, Joann G

    Published in PloS one (09-03-2023)
    “…Adaptive gain theory proposes that the dynamic shifts between exploration and exploitation control states are modulated by the locus coeruleus-norepinephrine…”
    Get full text
    Journal Article
  3. 3

    Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study by Wang, Hua, Atik, Anzari, Stewart, Tessandra, Ginghina, Carmen, Aro, Patrick, Kerr, Kathleen F., Seibyl, John, Jennings, Danna, Jensen, Poul Henning, Marek, Kenneth, Shi, Min, Zhang, Jing

    Published in Neurobiology of disease (01-08-2018)
    “…Plasma total and nervous system derived exosomal (NDE) α-synuclein have been determined as potential biomarkers of Parkinson's disease (PD). To explore the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Predicting individual cases of major adolescent psychiatric conditions with artificial intelligence by de Lacy, Nina, Ramshaw, Michael J., McCauley, Elizabeth, Kerr, Kathleen F., Kaufman, Joan, Nathan Kutz, J.

    Published in Translational psychiatry (10-10-2023)
    “…Three-quarters of lifetime mental illness occurs by the age of 24, but relatively little is known about how to robustly identify youth at risk to target…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    BioPETsurv: Methodology and open source software to evaluate biomarkers for prognostic enrichment of time-to-event clinical trials by Cheng, Si, Kerr, Kathleen F, Thiessen-Philbrook, Heather, Coca, Steven G, Parikh, Chirag R, Liu, Qin

    Published in PloS one (18-09-2020)
    “…Biomarkers can be used to enrich a clinical trial for patients at higher risk for an outcome, a strategy termed "prognostic enrichment." Methodology is needed…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use by Kerr, Kathleen F, Brown, Marshall D, Zhu, Kehao, Janes, Holly

    Published in Journal of clinical oncology (20-07-2016)
    “…The decision curve is a graphical summary recently proposed for assessing the potential clinical impact of risk prediction biomarkers or risk models for…”
    Get full text
    Journal Article
  12. 12

    Net Reclassification Index Statistics Do Not Help Assess New Risk Models by Kerr, Kathleen F

    Published in Radiology (01-03-2023)
    “…When evaluating a new risk factor for disease (eg, a measurement from imaging studies), many investigators examine its value above and beyond existing…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification by Ioannou, George N., Green, Pamela, Kerr, Kathleen F., Berry, Kristin

    Published in Journal of hepatology (01-09-2019)
    “…[Display omitted] •HCC risk varies dramatically in patients with cirrhosis.•We developed models estimating HCC risk in patients with NAFLD-cirrhosis or…”
    Get full text
    Journal Article
  16. 16

    Evaluating biomarkers for prognostic enrichment of clinical trials by Kerr, Kathleen F, Roth, Jeremy, Zhu, Kehao, Thiessen-Philbrook, Heather, Meisner, Allison, Wilson, Francis Perry, Coca, Steven, Parikh, Chirag R

    Published in Clinical trials (London, England) (01-12-2017)
    “…Background/Aims: A potential use of biomarkers is to assist in prognostic enrichment of clinical trials, where only patients at relatively higher risk for an…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20